These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35372028)

  • 1. High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis.
    Lai HY; Chiu CC; Kuo YH; Tsai HH; Wu LC; Tseng WH; Liu CL; Hsing CH; Huang SK; Li CF
    Front Oncol; 2022; 12():834249. PubMed ID: 35372028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma.
    Li WM; Chan TC; Huang SK; Wu WJ; Ke HL; Liang PI; Wei YC; Shiue YL; Li CF
    Front Oncol; 2020; 10():570340. PubMed ID: 33194662
    [No Abstract]   [Full Text] [Related]  

  • 3. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
    Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
    J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
    [No Abstract]   [Full Text] [Related]  

  • 4. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma.
    Kuo YH; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Lu JC; Li CF
    Onco Targets Ther; 2022; 15():727-740. PubMed ID: 35795328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
    Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
    Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis.
    Li WM; Chan TC; Wei YC; Li CF; Ke HL; Wu WJ; Hsu CC; Wang SC; Yeh CF
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):217. PubMed ID: 37796703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.
    Lee YY; Wu WJ; Huang CN; Li CC; Li WM; Yeh BW; Liang PI; Wu TF; Li CF
    J Cancer; 2016; 7(6):711-21. PubMed ID: 27076853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.
    Kuo YH; Chan TC; Lai HY; Chen TJ; Wu LC; Hsing CH; Li CF
    Front Oncol; 2021; 11():749142. PubMed ID: 34589439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
    Li WM; Ke HL; Kuo YH; Lai HY; Chan TC; Hsing CH; Hsieh KL; Li WS; Chen TJ; Wei YC; Wu WJ; Huang SK; Li CF
    Oncology; 2022; 100(9):485-497. PubMed ID: 35817020
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma.
    Yeh CF; Chan TC; Ke HL; Chen TJ; Wu LC; Lee HY; Wei YC; Wu WJ; Li CF; Li WM
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
    Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
    BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Lin JT; Chan TC; Li CF; Huan SKH; Tian YF; Liang PI; Pan CT; Shiue YL
    APMIS; 2019 Apr; 127(4):170-180. PubMed ID: 30803053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
    Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
    J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
    Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder.
    He HL; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Kuo YH; Shiue YL; Li CF
    World J Surg Oncol; 2023 Feb; 21(1):62. PubMed ID: 36841776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma.
    Chen TJ; Chan TC; Li WS; Li CF; Ke HL; Wei YC; Wu WJ; Li WM
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.